REVA Medical Inc.
5751 Copley Drive
News | June 05, 2015
REVA Medical Inc. announced the initiation of patient enrollment in the FANTOM II clinical trial of its Fantom...
News | February 12, 2015
A new stent for treating cardiovascular disease that incorporates a polymer invented at Rutgers, The State University...
News | December 31, 2014
Reva Medical initiated patient enrollment with its Fantom bioresorbable drug-eluting scaffold.
Feature | Stents Bioresorbable| September 03, 2014 | Dave Fornell
A key prediction for interventional cardiology coming out of recent Transcatheter Cardiovascular Therapeutics (TCT) and...
News | January 23, 2014
An implant of the ReZolve2 bioresorbable...
News | April 02, 2013
Reva Medical Inc. announced that it has initiated patient enrollment with its ReZolve2 bioresorbable sirolimus-eluting...
News | July 16, 2012
July 16, 2012 — Reva Medical Inc. announced it completed clinical enrollment with the ReZolve drug-eluting...